These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11710788)

  • 21. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
    Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatments and diets associated with resistant arterial hypertension and their influence on the efficacy of spironolactone.
    Quiñonez Quiñones NF; Santiago Ferrer JA; Burga Cisterna CA
    Nefrologia (Engl Ed); 2024; 44(3):439-440. PubMed ID: 38906768
    [No Abstract]   [Full Text] [Related]  

  • 23. Changes in selected metabolic parameters in patients over 65 receiving hydrochlorothiazide plus amiloride, atenolol or placebo in the MRC elderly trial.
    Damian DJ; McNamee R; Carr M
    BMC Cardiovasc Disord; 2016 Oct; 16(1):188. PubMed ID: 27716064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Medical treatment of arterial hypertension. Clinical study].
    Safar M; Schlotterer P; Lagrue G; Milliez P
    Presse Med (1893); 1971 Feb; 79(8):333-6. PubMed ID: 5552959
    [No Abstract]   [Full Text] [Related]  

  • 25. [Conn syndrome as cause of stubborn hypertension. Which hypertensives should you screen?].
    Reincke M
    MMW Fortschr Med; 2003 Feb; 145(9):37-40. PubMed ID: 12666528
    [No Abstract]   [Full Text] [Related]  

  • 26. Atenolol, bendrofluazide and their use in combination.
    Morgan TO
    J Hum Hypertens; 1998 Jul; 12(7):489. PubMed ID: 9702937
    [No Abstract]   [Full Text] [Related]  

  • 27. Multicentric clinical study on the antihypertensive efficacy of atenolol administered alone or with a diuretic combination.
    Sala G; Bignotti GC; Ratti G; Mascaretti L; Teruzzi L; Ronchi E; Franzini P; Girelli A; Pilotti A; Santambrogio C
    Farmaco Prat; 1983 Oct; 38(10):369-75. PubMed ID: 6653745
    [No Abstract]   [Full Text] [Related]  

  • 28. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
    Davis BR; Piller LB; Cutler JA; Furberg C; Dunn K; Franklin S; Goff D; Leenen F; Mohiuddin S; Papademetriou V; Proschan M; Ellsworth A; Golden J; Colon P; Crow R;
    Circulation; 2006 May; 113(18):2201-10. PubMed ID: 16651474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of the patient with resistant hypertension.
    Tarazi RC
    Hosp Pract (Off Ed); 1981 Jan; 16(1):49-57. PubMed ID: 6786972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends in Antihypertensive Medication Use Among US Patients With Resistant Hypertension, 2008 to 2014.
    Hwang AY; Dave C; Smith SM
    Hypertension; 2016 Dec; 68(6):1349-1354. PubMed ID: 27777360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [To protect the hypertensive patient from complications. Blood pressure lowering is not equal to blood pressure lowering].
    MMW Fortschr Med; 2003 Nov; 145(45):51. PubMed ID: 14712789
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of essential hypertension--its recent progress].
    Masuyama Y
    Nihon Rinsho; 1973 Nov; 31(11):3200-5. PubMed ID: 4149776
    [No Abstract]   [Full Text] [Related]  

  • 33. [PATHWAY-2 Study: spironolactone vs placebo, bisoprolol and doxazosin to determine optimal treatment of resistant hypertension. Spironolactone high effective in lowering blood pressure in drug resistant hypertension].
    Widimský J
    Vnitr Lek; 2015 Dec; 61(12):1067-71. PubMed ID: 26806502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Losartan for cardiovascular disease in patient's with and without diabetes in the LIFE study.
    Fuchs FD
    Lancet; 2002 Jun; 359(9324):2203; author reply 2203-4. PubMed ID: 12091010
    [No Abstract]   [Full Text] [Related]  

  • 35. Management of resistant hypertension: aldosterone antagonists or intensification of diuretic therapy?
    Verdalles U; García de Vinuesa S; Goicoechea M; Macías N; Santos A; Perez de Jose A; Verde E; Yuste C; Luño J
    Nephrology (Carlton); 2015 Aug; 20(8):567-71. PubMed ID: 25818266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Medical treatment of arterial hypertension: hemodynamic study].
    Safar M; Milliez P
    Rev Eur Etud Clin Biol; 1971 Apr; 16(4):334-42. PubMed ID: 5564545
    [No Abstract]   [Full Text] [Related]  

  • 37. Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT): a randomized, double-blind, placebo-controlled trial.
    Václavík J; Sedlák R; Plachy M; Navrátil K; Plásek J; Jarkovsky J; Václavík T; Husár R; Kociánová E; Táborsky M
    Hypertension; 2011 Jun; 57(6):1069-75. PubMed ID: 21536989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of thiazide and thiazide-potassium sparing diuretics on fibrinolytic system parameters.
    Kaşifoğlu T; Yalçin AU
    Anadolu Kardiyol Derg; 2006 Jun; 6(2):143-7. PubMed ID: 16766279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resistant hypertension.
    Tobe SW; Lewanczuk R
    Can J Cardiol; 2009 May; 25(5):315-7. PubMed ID: 19417863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Atenolol/nifedipine combination: efficacy and tolerability of low dose synergistic bitherapy in the treatment of arterial hypertension].
    Krivitzky A; Nguyen G; Gaudouen Y; Legrand M; Cohen R
    Drugs; 1998; 56 Suppl 2():31-43. PubMed ID: 9813740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.